The long-term impact of ferritin level on treatment and complications of type 2 diabetes

被引:2
|
作者
Jiang, L. [1 ]
Wang, A. [2 ]
Molyneaux, L. M. [3 ,4 ,5 ]
Constantino, M. I. [3 ,4 ]
Yue, D. K. [3 ,4 ,5 ]
机构
[1] Nanjing Med Univ, Affiliated Hosp 1, Dept Endocrinol, Nanjing, Jiangsu, Peoples R China
[2] 306 Hosp, Ctr Diabet, Beijing, Peoples R China
[3] Royal Prince Alfred Hosp, Ctr Diabet, Sydney, NSW, Australia
[4] Royal Prince Alfred Hosp, Dept Endocrinol, Sydney, NSW, Australia
[5] Univ Sydney, Discipline Med, Sydney, NSW 2006, Australia
来源
DIABETES OBESITY & METABOLISM | 2008年 / 10卷 / 06期
关键词
complications; ferritin; inflammation; insulin resistance; metabolic syndrome;
D O I
10.1111/j.1463-1326.2008.00855.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim: To investigate if high-serum ferritin has long-term impact on response to treatment and the development of diabetic complications in patients with type 2 diabetes. Research design and methods: We analysed the record of 90 consecutive type 2 diabetic subjects who had serum ferritin level determined soon after diagnosis of diabetes and who also had long-term follow-up data. Results: Patients with higher serum ferritin level had slightly worse triglyceride, blood pressure and liver enzyme levels at the end of follow up. However, ferritin level had no impact on the initial or final requirements for diabetic medication and the development of diabetic complications. Conclusions: Although elevated serum ferritin is a marker of insulin resistance and chronic inflammation, it is not necessarily a bad prognostic indicator that should affect the clinician's approach to management.
引用
收藏
页码:519 / 522
页数:4
相关论文
共 50 条
  • [11] Muscle fatigability in patients with type 2 diabetes: relation with long-term complications
    Orlando, Giorgio
    Sacchetti, Massimo
    D'Errico, Valeria
    Haxhi, Jonida
    Rapisarda, Gianvito
    Pugliese, Giuseppe
    Balducci, Stefano
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2020, 36 (02)
  • [12] Long-Term Incidence Rates of Complications in Patients with Type 2 Diabetes in Sweden
    Svensson, Ann-Marie
    Franzen, Stefan
    Klok, Rogier M.
    Weiss, Tracey
    Rajpathak, Swapnil
    Eliasson, Bjorn
    DIABETES, 2020, 69
  • [13] Inflammatory markers are elevated in type 1 and type 2 diabetes and linked to long-term complications
    van Heck, J. I. P.
    Stienstra, R.
    Joosten, L. A. B.
    Tack, C. J.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S117 - S118
  • [14] Adherence to treatment: The key for avoiding long-term complications of diabetes
    Lerman, I
    ARCHIVES OF MEDICAL RESEARCH, 2005, 36 (03) : 300 - 306
  • [15] Long-term Outcomes of bariatric Surgery for the Treatment of Type 2 Diabetes
    Kahl, S.
    DIABETOLOGIE, 2024, 20 (03): : 460 - 462
  • [16] Long-term complications in newly diagnosed patients with type 2 diabetes by regions of Serbia
    Rakocevic, I.
    Plavsic, S.
    Miljus, D.
    Katalina, N. Mickovski
    Knezevic, T.
    DIABETOLOGIA, 2009, 52 : S468 - S468
  • [17] Impact of Initial Treatment Policies on Long-term Complications and Costs in Japanese Patients with Type 2 Diabetes: A Real-World Database Study
    Yoshihara, Hiroshi
    Tonoike, Tohru
    Ohno, Hiromitsu
    Nishiuchi, Susumu
    Igarashi, Ataru
    DIABETES THERAPY, 2024, 15 (08) : 1811 - 1820
  • [18] COMPLICATIONS OF LONG-TERM DIABETES MELLITUS
    PAUL, JT
    PRESLEY, SJ
    ANNALS OF INTERNAL MEDICINE, 1958, 49 (01) : 142 - 150
  • [19] LONG-TERM COMPLICATIONS OF DIABETES - FOREWORD
    WATKINS, PJ
    CLINICS IN ENDOCRINOLOGY AND METABOLISM, 1986, 15 (04): : R9 - R9
  • [20] PREVENTION OF LONG-TERM COMPLICATIONS IN DIABETES
    SHIELD, JPH
    BAUM, JD
    ARCHIVES OF DISEASE IN CHILDHOOD, 1994, 70 (04) : 258 - 259